AC Immune SA (ACIU) income statement
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.95−0.18 (-8.45%)
Close on Nov 20, 2026Market cap $198.40MP/E –Yield –
AC Immune SA financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $198.40MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Operating margin | -1,940.1% | -191.8% | -362.3% | -1,800.4% | – | -397.0% | 40.3% | -716.9% | -111.3% | -45.0% | 47.6% | – |
| Pre-tax margin | -1,971.6% | -186.4% | -366.3% | -1,797.7% | – | -401.3% | 41.1% | -737.1% | -130.4% | -30.6% | 51.9% | – |
| Free cash flow margin | -1,963.7% | 239.0% | -413.5% | -1,901.1% | – | -396.8% | 48.3% | -664.6% | -118.0% | -28.2% | 112.2% | – |
| Effective tax rate | – | – | – | – | – | – | 0.00% | – | – | – | 0.00% | – |
| Returns on capital | ||||||||||||
| Return on equity | -89.7% | -37.3% | -32.9% | -35.3% | -32.6% | -25.4% | – | – | – | – | – | – |
| Return on capital employed | -73.1% | -35.0% | -31.2% | -34.1% | -33.9% | -24.2% | 19.1% | -32.4% | -16.8% | -7.2% | – | – |
| NOPAT | -54.76M | -41.38M | -42.36M | -55.97M | -62.42M | -48.40M | 44.54M | -39.14M | -17.81M | -8.26M | 18.62M | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -1,938.5% | 241.1% | -408.1% | -1,869.6% | – | -385.7% | 50.0% | -637.7% | -109.1% | -24.3% | 112.8% | – |
| FCF / OCF | 101.3% | 99.1% | 101.3% | 101.7% | 104.0% | 102.9% | 96.6% | 104.2% | 108.2% | 115.9% | 99.4% | – |
| Unlevered free cash flow | -70.01M | 65.37M | -61.07M | -74.53M | -67.87M | -61.08M | 54.86M | -45.67M | -23.78M | -6.54M | 43.84M | – |
| Levered free cash flow | -70.16M | 65.27M | -61.21M | -74.81M | -68.32M | -61.22M | 53.34M | -45.94M | -23.90M | -6.55M | 43.84M | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.02 | 0.13 | 0.08 | 0.02 | 0.00 | 0.06 | 0.45 | 0.04 | 0.14 | 0.15 | – | – |
| Fixed asset turnover | 1.54 | 9.06 | 3.88 | 0.84 | 0.00 | 3.70 | 30.51 | 2.44 | 11.66 | 28.66 | 78.18 | – |
| Receivables turnover | – | 3.69 | 1.00 | – | – | – | – | – | – | – | – | – |
| Days sales outstanding | – | 98.9 | 365.0 | – | – | – | – | – | – | – | – | – |
| CapEx to revenue | 25.2% | 2.1% | 5.4% | 31.5% | – | 11.1% | 1.7% | 26.9% | 8.9% | 3.9% | 0.62% | – |
| CapEx to OCF | -1.3% | 0.87% | -1.3% | -1.7% | -4.0% | -2.9% | 3.4% | -4.2% | -8.2% | -15.9% | 0.55% | – |
| Liquidity | ||||||||||||
| Current ratio | 1.02 | 1.71 | 9.22 | 11.16 | 10.12 | 16.53 | 16.72 | 14.75 | 13.28 | 15.61 | – | – |
| Quick ratio | 1.02 | 1.71 | 9.22 | 11.16 | 10.12 | 16.53 | 16.72 | 14.75 | 13.28 | 15.61 | – | – |
| Cash ratio | 0.28 | 0.36 | 5.78 | 2.75 | 4.11 | 11.48 | 11.06 | 11.96 | 12.75 | 15.34 | – | – |
| Working capital | 2.03M | 71.16M | 111.58M | 116.61M | 182.61M | 217.75M | 275.26M | 179.85M | 119.78M | 144.97M | – | – |
| Net current asset value | -12.65M | 53.35M | 102.98M | 111.15M | 173.17M | 208.51M | 265.97M | 174.00M | 114.36M | 141.17M | – | – |
| Leverage | ||||||||||||
| Assets to equity | 3.44 | 2.06 | 1.14 | 1.10 | 1.13 | 1.11 | 1.10 | 1.11 | 1.13 | 1.10 | – | – |
| Intangibles to total assets | 32.7% | 21.8% | 27.6% | 27.1% | 19.3% | 0.00% | – | – | – | – | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -362.92 | -393.82 | -304.68 | -199.57 | -135.99 | -332.93 | 23.12 | -148.35 | -153.33 | -1,493.71 | – | – |
| Per share | ||||||||||||
| Revenue per share | 0.04 | 0.27 | 0.17 | 0.05 | 0.00 | 0.21 | 1.55 | 0.11 | 0.35 | 0.46 | 0.85 | – |
| EPS (basic) | -0.70 | -0.51 | -0.64 | -0.85 | -0.97 | -0.86 | 0.64 | -0.82 | -0.46 | -0.14 | 0.47 | – |
| EPS (diluted) | -0.70 | -0.51 | -0.64 | -0.85 | -0.97 | -0.86 | 0.64 | -0.82 | -0.46 | -0.14 | 0.44 | – |
| Book value per share | 0.45 | 1.13 | 1.90 | 2.02 | 3.10 | 3.00 | 3.83 | 2.87 | 2.05 | 2.84 | 1.54 | – |
| Tangible book value per share | -0.05 | 0.62 | 1.30 | 1.42 | 2.42 | 3.00 | 3.83 | 2.87 | 2.05 | 2.84 | 1.54 | – |
| Cash per share | 0.27 | 0.36 | 0.93 | 0.38 | 1.10 | 2.24 | 2.72 | 2.53 | 2.18 | 3.04 | 1.66 | – |
| Operating cash flow per share | -0.69 | 0.66 | -0.71 | -0.88 | -0.88 | -0.83 | 0.78 | -0.71 | -0.39 | -0.11 | 0.96 | – |
| Free cash flow per share | -0.70 | 0.65 | -0.72 | -0.90 | -0.91 | -0.85 | 0.75 | -0.74 | -0.42 | -0.13 | 0.95 | – |
| CapEx per share | 0.0089 | 0.0058 | 0.0095 | 0.01 | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.0053 | – |
| Valuation at period end | ||||||||||||
| Market cap | 313.03M | 228.68M | 417.77M | 152.90M | 355.91M | 367.60M | 526.86M | 562.40M | 641.24M | 597.64M | – | – |
| Enterprise value | 280.62M | 171.81M | 370.17M | 104.74M | 179.99M | 148.64M | 365.18M | 435.89M | 484.93M | 522.32M | – | – |
| P/S | 87.6x | 8.4x | 28.2x | 38.9x | – | 23.8x | 4.8x | 81.4x | 31.7x | 25.7x | – | – |
| P/B | 7.0x | 2.0x | 2.6x | 0.9x | 1.5x | 1.7x | 1.9x | 3.2x | 5.5x | 4.2x | – | – |
| P/TBV | -56.6x | 3.7x | 3.8x | 1.3x | 2.0x | 1.7x | 1.9x | 3.2x | 5.5x | 4.2x | – | – |
| P/OCF | -4.5x | 3.5x | -6.9x | -2.1x | -5.4x | -6.2x | 9.5x | – | – | -106x | – | – |
| P/FCF | – | 3.5x | – | – | – | – | 9.9x | – | – | – | – | – |
| EV/Sales | 78.5x | 6.3x | 25.0x | 26.6x | – | 9.6x | 3.3x | 63.1x | 23.9x | 22.5x | – | – |
| EV/EBIT | – | – | – | – | – | – | 8.2x | – | – | – | – | – |
| EV/OCF | -4.1x | 2.6x | -6.1x | -1.4x | -2.7x | -2.5x | 6.6x | – | – | -92.5x | – | – |
| EV/FCF | – | 2.6x | – | – | – | – | 6.8x | – | – | – | – | – |
| FCF yield | -22.4% | 28.5% | -14.7% | -48.9% | -19.2% | -16.7% | 10.1% | – | – | -1.1% | – | – |
| Shareholder yield | ||||||||||||
| Buyback yield | – | – | – | – | – | 0.03% | 0.00% | – | – | – | – | – |
| Shareholder yield | – | – | – | – | – | 0.03% | 0.00% | – | – | – | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | 1,579.5% | 229.1% | 368.9% | 1,533.3% | – | 385.5% | 45.7% | 640.6% | 161.3% | 111.0% | 43.6% | – |
| SG&A to revenue | – | – | – | – | – | 120.3% | 14.5% | 180.4% | 50.0% | 34.0% | 8.7% | – |
| Stock-based comp to revenue | 123.0% | 20.0% | 29.5% | 84.6% | – | 26.5% | 2.6% | 36.4% | 7.8% | 5.7% | 1.4% | – |
| Per employee | ||||||||||||
| Total employees | 122 | 172 | 161 | 156 | 143 | 149 | 132 | 104 | 86 | 67 | 67 | 67 |
| Revenue per employee | 29.29K | 158.77K | 91.93K | 25.22K | 0 | 103.56K | 836.79K | 66.46K | 235.52K | 346.48K | 583.43K | – |
| Operating profit per employee | -568.18K | -304.52K | -333.07K | -454.15K | -552.52K | -411.14K | 337.39K | -476.44K | -262.08K | -156.06K | 277.97K | – |
| Free cash flow per employee | -575.10K | 379.45K | -380.18K | -479.53K | -477.79K | -410.89K | 404.05K | – | – | -97.69K | 654.33K | – |
| Growth | ||||||||||||
| Revenue 1Y growth | -86.9% | 84.5% | 276.1% | – | -100.0% | -86.0% | 1,498.0% | -65.9% | -12.7% | -40.6% | – | – |
| Revenue 3Y CAGR | -3.2% | – | -1.4% | -67.1% | – | -8.7% | 68.2% | -43.9% | – | – | – | – |
| Revenue 5Y CAGR | -25.4% | -24.4% | 16.4% | -27.9% | – | -17.0% | – | – | – | – | – | – |
| Revenue 10Y CAGR | -21.3% | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -32.3% | 2.3% | 24.3% | 10.3% | -29.0% | -237.6% | 189.9% | -119.8% | -115.6% | -156.1% | – | – |
| Diluted EPS 1Y growth | -37.3% | 20.3% | 24.7% | 12.4% | -12.8% | -234.4% | 178.0% | -78.3% | -228.6% | -131.8% | – | – |
| Operating cash flow 1Y growth | -205.2% | 209.0% | 17.9% | -12.0% | -10.4% | -207.8% | 225.3% | -99.5% | -291.3% | -112.8% | – | – |
| Operating cash flow 5Y CAGR | – | 3.6% | – | – | – | – | – | – | – | – | – | – |
| Free cash flow 1Y growth | -207.5% | 206.6% | 18.2% | -9.5% | -11.6% | -214.8% | 216.1% | -92.2% | -265.1% | -114.9% | – | – |
| Free cash flow 5Y CAGR | – | 4.1% | – | – | – | – | – | – | – | – | – | – |
| CapEx 1Y growth | 56.3% | -28.1% | -35.4% | -53.0% | 54.5% | -9.5% | 1.5% | 3.1% | 100.4% | 268.4% | – | – |
| CapEx 3Y CAGR | -10.1% | -39.8% | -22.3% | -13.1% | 12.4% | -1.8% | 28.0% | 96.7% | – | – | – | – |
| CapEx 5Y CAGR | -12.0% | -21.1% | -15.5% | -7.2% | 24.0% | 47.5% | – | – | – | – | – | – |
| CapEx 10Y CAGR | 13.9% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -33.2% | 26.3% | -1.7% | -28.9% | 9.5% | -20.2% | 52.2% | 48.9% | -15.4% | – | – | – |
| Total assets 3Y CAGR | -6.0% | -4.1% | -8.5% | -14.7% | 10.0% | 21.8% | 24.2% | – | – | – | – | – |
| Total assets 5Y CAGR | -8.4% | -5.1% | -1.4% | 7.1% | 10.9% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.